Westbourne Investment Advisors Inc. lowered its holdings in Procter & Gamble (NYSE:PG) by 12.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 13,200 shares of the company’s stock after selling 1,925 shares during the quarter. Westbourne Investment Advisors Inc.’s holdings in Procter & Gamble were worth $1,213,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in PG. Harding Loevner LP purchased a new position in Procter & Gamble during the 2nd quarter worth approximately $119,000. Cerebellum GP LLC purchased a new position in Procter & Gamble during the 4th quarter worth approximately $122,000. Kohmann Bosshard Financial Services LLC purchased a new position in Procter & Gamble during the 3rd quarter worth approximately $125,000. Blume Capital Management Inc. grew its stake in Procter & Gamble by 25.4% during the 2nd quarter. Blume Capital Management Inc. now owns 1,482 shares of the company’s stock worth $129,000 after buying an additional 300 shares during the last quarter. Finally, James Investment Research Inc. grew its stake in Procter & Gamble by 400.0% during the 4th quarter. James Investment Research Inc. now owns 1,500 shares of the company’s stock worth $138,000 after buying an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.

How to Become a New Pot Stock Millionaire

PG opened at $78.61 on Tuesday. The company has a quick ratio of 0.79, a current ratio of 0.94 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $197,571.08, a PE ratio of 20.05, a price-to-earnings-growth ratio of 2.49 and a beta of 0.56. Procter & Gamble has a 12 month low of $75.81 and a 12 month high of $94.67.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, January 23rd. The company reported $1.19 EPS for the quarter, beating the consensus estimate of $1.14 by $0.05. The business had revenue of $17.40 billion during the quarter, compared to analysts’ expectations of $17.39 billion. Procter & Gamble had a return on equity of 20.66% and a net margin of 15.34%. The company’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same period last year, the firm earned $1.08 EPS. research analysts forecast that Procter & Gamble will post 4.17 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be issued a $0.7172 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.69. This represents a $2.87 annualized dividend and a dividend yield of 3.65%. The ex-dividend date is Thursday, April 19th. Procter & Gamble’s dividend payout ratio (DPR) is currently 70.41%.

PG has been the subject of a number of recent research reports. Zacks Investment Research raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 price objective for the company in a research report on Monday, January 8th. Morgan Stanley decreased their price objective on Procter & Gamble from $92.00 to $85.00 and set an “equal weight” rating for the company in a research report on Thursday, April 5th. Goldman Sachs raised Procter & Gamble from a “sell” rating to a “neutral” rating and set a $77.00 price objective for the company in a research report on Tuesday, January 16th. Deutsche Bank initiated coverage on Procter & Gamble in a research report on Tuesday, December 19th. They set a “buy” rating and a $91.88 price objective for the company. Finally, Barclays set a $84.00 price objective on Procter & Gamble and gave the stock a “hold” rating in a research report on Thursday, March 15th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. Procter & Gamble currently has an average rating of “Hold” and an average target price of $85.52.

In other news, insider Marylynn Fergusonmchugh sold 2,353 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $78.59, for a total value of $184,922.27. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Marc S. Pritchard sold 46,842 shares of the firm’s stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $89.01, for a total value of $4,169,406.42. The disclosure for this sale can be found here. Insiders sold a total of 114,011 shares of company stock valued at $9,710,976 over the last three months. Insiders own 0.35% of the company’s stock.

WARNING: This article was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.dailypolitical.com/2018/04/17/procter-gamble-pg-stake-lowered-by-westbourne-investment-advisors-inc.html.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in the United States, Canada, Puerto Rico, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company's Beauty segment offers hair care products, including conditioners, shampoos, styling aids, and treatments; and skin and personal care products, such as antiperspirant and deodorant, personal cleansing, and skin care products.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.